Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma

Objective: Pancreatic ductal adenocarcinoma (PDAC) is highly lethal. Although progress has been made in the treatment of PDAC, its prognosis remains unsatisfactory. This study aimed to develop novel prognostic genes related to glycolysis in PDAC and to apply these genes to new risk stratification.Me...

Full description

Bibliographic Details
Main Authors:	Wenjing Song, Xin He, Pengju Gong, Yan Yang, Sirui Huang, Yifan Zeng, Lei Wei, Jingwei Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Genetics
Subjects:	glycolysis gene signature overall survival prognostic biomarker pancreatic ductal adenocarcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2021.639246/full

Similar Items

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
by: Chenhao Zhou, et al.
Published: (2019-11-01)

Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
by: Hweixian Leong Penny, et al.
Published: (2021-06-01)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-05-01)

Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma
by: Shinichiro Yamada, et al.
Published: (2021-03-01)

Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma
by: Zengyu Feng, et al.
Published: (2020-09-01)

A Novel DNA Replication-Related Signature Predicting Recurrence After R0 Resection of Pancreatic Ductal Adenocarcinoma: Prognostic Value and Clinical Implications
by: Zengyu Feng, et al.
Published: (2021-03-01)

Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
by: Liao X, et al.
Published: (2017-09-01)

C-Reactive Protein/Albumin Ratio and Prognostic Nutritional Index Are Strong Prognostic Indicators of Survival in Resected Pancreatic Ductal Adenocarcinoma
by: Masahide Ikeguchi, et al.
Published: (2017-07-01)

Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
by: Yuzhen Gao, et al.
Published: (2020-09-01)

The Prognostic Value of Preoperative Geriatric Nutritional Risk Index in Patients with Pancreatic Ductal Adenocarcinoma
by: Hu SP, et al.
Published: (2020-01-01)

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis
by: Yousra Mohamed Abd-El-Halim, et al.
Published: (2021-09-01)

A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-09-01)

Circular RNA Circ_0001017 acts as ceRNA adsorbing miR-197-3p to regulate PNLIP signaling and affect the proliferation, apoptosis and glycolysis of pancreatic ductal adenocarcinoma cells
by: Hu, Q., et al.
Published: (2021)

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
by: Weijia Wang, et al.
Published: (2021-02-01)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
by: Dongjie Chen, et al.
Published: (2021-10-01)

Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis
by: Ke Zhang, et al.
Published: (2020-06-01)

Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms
by: Jun-Qi Liu, et al.
Published: (2020-12-01)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
by: He Xu, et al.
Published: (2021-02-01)

Identification of a robust functional subpathway signature for pancreatic ductal adenocarcinoma by comprehensive and integrated analyses
by: Ping Wang, et al.
Published: (2020-03-01)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
by: Christelle d’Engremont, et al.
Published: (2021-05-01)

Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study
by: Jun-Chao Guo, et al.
Published: (2020-05-01)

Identification of a Five-Gene Prognostic Signature Related to B Cells Infiltration in Pancreatic Adenocarcinoma
by: Tang S, et al.
Published: (2021-08-01)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
by: Yizhi Wang, et al.
Published: (2020-09-01)

Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
by: Haoda Chen, et al.
Published: (2021-06-01)

Phosphomannose Isomerase High Expression Associated with Better Prognosis in Pancreatic Ductal Adenocarcinoma
by: Alipour Z, et al.
Published: (2021-09-01)

Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in one medical center
by: Chih-Po Hsu, et al.
Published: (2018-03-01)

Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease
by: Sutaryo Sutaryo, et al.
Published: (2020-11-01)

LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway
by: Ming Xu, et al.
Published: (2021-12-01)

Aberrant downstream mechanisms following depletion of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma
by: Dawkins, Joshua Benjamin Newton
Published: (2017)

Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma
by: Sohei Satoi, et al.
Published: (2020-01-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Kongyuan Wei, et al.
Published: (2021-04-01)

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
by: Dan Wang, et al.
Published: (2020-05-01)

A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
by: Aisha Al-Dherasi, et al.
Published: (2021-06-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
by: Byeong Geun Song, et al.
Published: (2021-02-01)

Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma
by: Julie Schnipper, et al.
Published: (2020-10-01)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01)

CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma – a quantitative analysis
by: Armin Eilaghi, et al.
Published: (2017-06-01)